- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 17/02 - Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Patent holdings for IPC class A61P 17/02
Total number of patents in this class: 4663
10-year publication summary
138
|
140
|
227
|
345
|
343
|
356
|
399
|
377
|
381
|
274
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 20137 |
27 |
Allergan, Inc. | 2334 |
24 |
Agency for Science, Technology and Research | 3659 |
22 |
Centre National de La Recherche Scientifique | 10576 |
21 |
University of Pittsburgh - Of the Commonwealth System of Higher Education | 3186 |
17 |
Osaka University | 3394 |
15 |
RENOVO Limited | 32 |
15 |
The Board of Trustees of the Leland Stanford Junior University | 6487 |
14 |
The Johns Hopkins University | 5723 |
14 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3368 |
14 |
KLOX Technologies Inc. | 69 |
14 |
Nanyang Technological University | 2048 |
14 |
Daiichi Sankyo Company, Limited | 1875 |
13 |
Shionogi & Co., Ltd. | 843 |
12 |
MiMedx Group, Inc. | 207 |
11 |
Nippon Shinyaku Co., Ltd. | 323 |
11 |
Shiseido Company, Ltd. | 4118 |
11 |
EnliTISA (Shanghai) Pharmaceutical Co., Ltd. | 29 |
11 |
The Trustees of the University of Pennsylvania | 4354 |
10 |
Mayo Foundation for Medical Education and Research | 3257 |
10 |
Other owners | 4363 |